Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Aug;74(8):1085–1089. doi: 10.1136/jnnp.74.8.1085

Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls

M Silva 1, P Mattos 1, A Alfano 1, A Araujo 1
PMCID: PMC1738599  PMID: 12876239

Abstract

Background: Human T cell lymphotropic virus type 1 (HTLV-I) can cause tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM) and adult T cell leukaemia/lymphoma. More recently other diseases such as isolated peripheral polyneuropathy, myopathy, artropathy, and uveitis have been associated with this retrovirus. Only a few uncontrolled studies, without necessary exclusion criteria, have described mild cognitive deficits among TSP/HAM patients. To further clarify this the authors evaluated, through neuropsychological testing patients with TSP/HAM and asymptomatic infected carriers, comparing both groups with healthy controls.

Objectives: To verify the presence of cognitive deficits among TSP/HAM patients and asymptomatic HTLV-1 infected carriers. In addition, the authors aimed to investigate if these deficits correlated with the degree of motor impairment in TSP/HAM patients.

Methods: From a cohort of 501 HTLV-1 infected people the authors selected, according to predefined inclusion and exclusion criteria, 40 asymptomatic HTLV-1 carriers and 37 TSP/HAM patients. Neuropsychological testing was blindly performed in both groups and their scores were compared with those obtained from controls.

Results: Both the HTLV-1 carrier group and the group of patients with TSP/HAM exhibited a lower performance in neuropsychological tests when compared with controls. Asymptomatic infected carriers and TSP/HAM patients did not differ in their cognitive results. Also, there was no relation between the degree of motor disability and cognitive deficits in the TSP/HAM group. Psychomotor slowing and deficits in the some domains characterised the neuropsychological impairment in HTLV-1 infection: verbal and visual memory, attention and visuomotor abilities.

Conclusions: TSP/HAM as well as asymptomatic infection can be associated with mild cognitive deficits. This finding, if confirmed by further studies, will permit the inclusion of cognitive impairment among the neurological manifestations of HTLV-1.

Full Text

The Full Text of this article is available as a PDF (160.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akizuki S., Setoguchi M., Nakazato O., Yoshida S., Higuchi Y., Yamamoto S., Okajima T. An autopsy case of human T-lymphotropic virus type I-associated myelopathy. Hum Pathol. 1988 Aug;19(8):988–990. doi: 10.1016/s0046-8177(88)80017-0. [DOI] [PubMed] [Google Scholar]
  2. Bhigjee A. I., Bill P. L., Wiley C. A., Windsor I. M., Matthias D. A., Amenomori T., Wachsman W., Moorhouse D. Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP). Muscle Nerve. 1993 Jan;16(1):21–26. doi: 10.1002/mus.880160106. [DOI] [PubMed] [Google Scholar]
  3. Biddison W. E., Kubota R., Kawanishi T., Taub D. D., Cruikshank W. W., Center D. M., Connor E. W., Utz U., Jacobson S. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol. 1997 Aug 15;159(4):2018–2025. [PubMed] [Google Scholar]
  4. Brandt J., Folstein S. E., Folstein M. F. Differential cognitive impairment in Alzheimer's disease and Huntington's disease. Ann Neurol. 1988 Jun;23(6):555–561. doi: 10.1002/ana.410230605. [DOI] [PubMed] [Google Scholar]
  5. Cartier L., Gormaz A. Demencia subcortical en paraparesia espástica tropical asociada a HTLV-I: estudio de 43 casos. Rev Med Chil. 1999 Apr;127(4):444–450. [PubMed] [Google Scholar]
  6. Cartier L., Gormaz A., Kleinsteuber K., Ramírez E., Galeno H. Nueva forma de demencia subcortical: encefalopatía por infección del virus linfotrópico T humano (HTLV-I). Caso Clínico. Rev Med Chil. 1997 Feb;125(2):209–213. [PubMed] [Google Scholar]
  7. Filley C. M. The behavioral neurology of cerebral white matter. Neurology. 1998 Jun;50(6):1535–1540. doi: 10.1212/wnl.50.6.1535. [DOI] [PubMed] [Google Scholar]
  8. Fukushima T., Ikeda T., Uyama E., Uchino M., Okabe H., Ando M. Cognitive event-related potentials and brain magnetic resonance imaging in HTLV-1 associated myelopathy (HAM). J Neurol Sci. 1994 Oct;126(1):30–39. doi: 10.1016/0022-510x(94)90091-4. [DOI] [PubMed] [Google Scholar]
  9. Janssen R. S., Saykin A. J., Kaplan J. E., Spira T. J., Pinsky P. F., Sprehn G. C., Hoffman J. C., Mayer W. B., Jr, Schonberger L. B. Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome. Ann Neurol. 1988 Jan;23(1):49–55. doi: 10.1002/ana.410230109. [DOI] [PubMed] [Google Scholar]
  10. Janssen R. S., Saykin A. J., Kaplan J. E., Spira T. J., Pinsky P. F., Sprehn G. C., Hoffman J. C., Mayer W. B., Jr, Schonberger L. B. Neurological symptoms and neuropsychological abnormalities in lymphadenopathy syndrome. Ann Neurol. 1988;23 (Suppl):S17–S18. doi: 10.1002/ana.410230708. [DOI] [PubMed] [Google Scholar]
  11. Kira J., Fujihara K., Itoyama Y., Goto I., Hasuo K. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci. 1991 Nov;106(1):41–49. doi: 10.1016/0022-510x(91)90192-a. [DOI] [PubMed] [Google Scholar]
  12. Kira J., Hamada T., Kawano Y., Okayama M., Yamasaki K. An association of human T-cell lymphotropic virus type I infection with vascular dementia. Acta Neurol Scand. 1997 Nov;96(5):305–309. doi: 10.1111/j.1600-0404.1997.tb00288.x. [DOI] [PubMed] [Google Scholar]
  13. Krämer A., Maloney E. M., Morgan O. S., Rodgers-Johnson P., Manns A., Murphy E. L., Larsen S., Cranston B., Murphy J., Benichou J. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. Am J Epidemiol. 1995 Dec 1;142(11):1212–1220. doi: 10.1093/oxfordjournals.aje.a117580. [DOI] [PubMed] [Google Scholar]
  14. Leite AC. Prevalence study of neurologic manifestations in HTLV-I positive blood donors. Arq Neuropsiquiatr. 2000 Mar;58(1):195–195. doi: 10.1590/s0004-282x2000000100031. [DOI] [PubMed] [Google Scholar]
  15. Lycke J., Svennerholm B., Svenningsson A., Horal P., Nordqvist-Brandt E., Andersen O. Possible association of HTLV-I infection and dementia. Acta Neurol Scand. 1993 Sep;88(3):199–203. doi: 10.1111/j.1600-0404.1993.tb04216.x. [DOI] [PubMed] [Google Scholar]
  16. Manns A., Miley W. J., Wilks R. J., Morgan O. S., Hanchard B., Wharfe G., Cranston B., Maloney E., Welles S. L., Blattner W. A. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis. 1999 Nov;180(5):1487–1493. doi: 10.1086/315088. [DOI] [PubMed] [Google Scholar]
  17. Mora C. A., Garruto R. M., Brown P., Guiroy D., Morgan O. S., Rodgers-Johnson P., Ceroni M., Yanagihara R., Goldfarb L. G., Gibbs C. J., Jr Seroprevalence of antibodies to HTLV-I in patients with chronic neurological disorders other than tropical spastic paraparesis. Ann Neurol. 1988;23 (Suppl):S192–S195. doi: 10.1002/ana.410230743. [DOI] [PubMed] [Google Scholar]
  18. Nakao K., Isashiki Y., Uto M., Ohba N., Kawano K. [Antibodies to human T-cell lymphotropic virus type 1 in the aqueous humor of HTLV-I associated uveitis]. Nippon Ganka Gakkai Zasshi. 1994 Sep;98(9):866–871. [PubMed] [Google Scholar]
  19. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
  20. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stoolman L. M. Adhesion molecules controlling lymphocyte migration. Cell. 1989 Mar 24;56(6):907–910. doi: 10.1016/0092-8674(89)90620-x. [DOI] [PubMed] [Google Scholar]
  22. Sulkava R., Korpela J., Erkinjuntti T. No antibodies to HTLV-I and HIV in patients with dementia in Finland. Acta Neurol Scand. 1987 Aug;76(2):155–156. doi: 10.1111/j.1600-0404.1987.tb03560.x. [DOI] [PubMed] [Google Scholar]
  23. Taylor G. P., Tosswill J. H., Matutes E., Daenke S., Hall S., Bain B. J., Davis R., Thomas D., Rossor M., Bangham C. R. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):92–100. doi: 10.1097/00042560-199909010-00012. [DOI] [PubMed] [Google Scholar]
  24. Tournier-Lasserve E., Gout O., Gessain A., Iba-Zizen M. T., Lyon-Caen O., Lhermitte F., de-Thé G. HTLV-I, brain abnormalities on magnetic resonance imaging, and relation with multiple sclerosis. Lancet. 1987 Jul 4;2(8549):49–50. doi: 10.1016/s0140-6736(87)93092-3. [DOI] [PubMed] [Google Scholar]
  25. Vernant J. C., Smadja D., Deforge-Lasseur C., Cabre P., Buisson G., Neisson-Vernant C., Desgranges C. Vascularites et manifestations neurologiques liées au HTLV-1. Presse Med. 1994 Oct 15;23(31):1421–1425. [PubMed] [Google Scholar]
  26. Yoshida S., Minakawa T., Takai N., Tanaka R. Effects of cytokines on cultured microvascular endothelial cells derived from gerbil brain. Neurosurgery. 1989 Sep;25(3):373–377. doi: 10.1097/00006123-198909000-00009. [DOI] [PubMed] [Google Scholar]
  27. Yu F., Itoyama Y., Kira J., Fujihara K., Kobayashi T., Kitamoto T., Suzumura A., Yamamoto N., Nakajima Y., Goto I. TNF-beta produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts. J Immunol. 1994 Jun 15;152(12):5930–5938. [PubMed] [Google Scholar]
  28. de Groot J. C., de Leeuw F. E., Oudkerk M., van Gijn J., Hofman A., Jolles J., Breteler M. M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000 Feb;47(2):145–151. doi: 10.1002/1531-8249(200002)47:2<145::aid-ana3>3.3.co;2-g. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES